How far does a new horizon extend for rucaparib in metastatic prostate cancer?

Fatima Karzai; Ravi A. Madan; William D. Figg

doi:10.21037/tcr-23-1563

How far does a new horizon extend for rucaparib in metastatic prostate cancer?

Fatima Karzai, Ravi A. Madan, William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	11-14
Number of pages	4
Journal	Translational Cancer Research
Volume	13
Issue number	1
DOIs	https://doi.org/10.21037/tcr-23-1563
State	Published - 2024
Externally published	Yes

Keywords

BRCA
Rucaparib
metastatic
prostate cancer

Access to Document

10.21037/tcr-23-1563

Cite this

@article{69128b7a99c14e8590d8d126590bf905,

title = "How far does a new horizon extend for rucaparib in metastatic prostate cancer?",

keywords = "BRCA, Rucaparib, metastatic, prostate cancer",

author = "Fatima Karzai and Madan, {Ravi A.} and Figg, {William D.}",

year = "2024",

doi = "10.21037/tcr-23-1563",

language = "English",

volume = "13",

pages = "11--14",

journal = "Translational Cancer Research",

issn = "2218-676X",